Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carbamazepine alone versus carbamazepine + lacosamide in uncontrolled epilepsy
IRCT20231128060214N1Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of carbamazepine and lacosamide in epilepsy (2 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoint: Number of seizure events at 6 months. Started Mar 2024; status: completed.
02
Drugs
carbamazepinelacosamide
03
Conditions
epilepsy
Beyond the preview
Go deeper on IRCT20231128060214N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20231128060214N1.